Report of Foreign Issuer (6-k)
March 14 2018 - 6:05AM
Edgar (US Regulatory)
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Month of March, 2018
Commission File Number: 001-35892
GW
PHARMACEUTICALS PLC
(Translation of registrant’s name
into English)
Sovereign
House
Vision
Park
Histon
Cambridge
CB24 9BZ
United
Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Notification of Interests Of Directors,
Officers And Connected Persons
GW Pharmaceuticals plc (the “Company”)
hereby provides notification that on March 8, 2018, Adam George, Company Secretary and UK Managing Director exercised options under
the Company’s Long Term Incentive Plan and sold 17,200 American Depositary Shares (“ADSs”) at a price of $116.67
per ADS in accordance with his Rule 10b5-1 plan established February 14, 2018. Further details are set forth in the table below.
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
a.
|
Name
|
Adam George
|
2.
|
Reason for the notification
|
a.
|
Position/status
|
UK Managing Director
|
b.
|
Initial notification /Amendment
|
Initial notification
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
a.
|
Name
|
GW Pharmaceuticals PLC
|
b.
|
LEI
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
a.
|
Description of the Financial instrument, type of instrument
Identification code
|
American Depositary Shares
ISIN: 36197T1034
|
b.
|
Nature of the transaction
|
Exercise of Long Term Incentive Plan options and sale of resulting American Depositary Shares in accordance with 10b5.1 plan dated 14 February 2018
|
c.
|
Price(s) and volume(s)
|
Price(s)
$116.67
|
Volume(s)
17,200
|
ADS’s sold
|
d.
|
Aggregated information
·
Aggregated
volume
·
Price
|
n/a
|
e.
|
Date of the transaction
|
March 8, 2018
|
f.
|
Place of the transaction
|
Nasdaq, New York
|
For further information, please contact:
GW Pharmaceuticals PLC
|
+44 (0)1980 557 000
|
Adam George, Company Secretary
|
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
GW Pharmaceuticals plc
|
|
|
|
|
By:
|
/s/ Adam George
|
|
Name:
|
Adam George
|
|
Title:
|
Company Secretary
|
|
|
|
Date: March 13, 2018
|
|
|